Differential Effects of Falcarinol and Related Aliphatic C17-Polyacetylenes on Intestinal Cell Proliferation by Purup, Stig et al.
pubs.acs.org/JAFC Published on Web 08/20/2009 ©2009 American Chemical Society
8290 J. Agric. Food Chem. 2009, 57, 8290–8296
DOI:10.1021/jf901503a
Differential Effects of Falcarinol and Related Aliphatic
C17-Polyacetylenes on Intestinal Cell Proliferation
STIG PURUP,*
,† ERIC LARSEN,
†
AND LARS P. CHRISTENSEN
‡
†Department of Animal Health, Welfare and Nutrition, Faculty of Agricultural Sciences, Aarhus
University, Blichers Alle ´ 20, P.O. Box 50, DK-8830 Tjele, Denmark, and
‡Institute of Chemical
Engineering, Biotechnology and Environmental Technology, Faculty of Engineering, University of
Southern Denmark, Niels Bohrs Alle ´ 1, DK-5230 Odense M, Denmark
Quantitative major polyacetylenes of carrots (falcarinol and falcarindiol) and American ginseng roots
(falcarinol and panaxydol) were isolated and tested in human intestinal epithelial cells of normal
(FHs 74 Int.) and cancer (Caco-2) origin. A hormesis effect was seen for all isolated polyacetylenes
when added to Caco-2 cells in concentrations ranging from 1 ng/mL to 20 μg/mL. The relative
inhibitory potency was falcarinol > panaxydol > falcarindiol. No hormesis effect was observed when
adding the polyacetylenes to FHs 74 Int. cells. Instead, an inhibitory growth response was observed
above 1 μg/mL. The relative inhibitory potency was panaxydol > falcarinol > falcarindiol. Maximal
inhibition at 20 μg/mL corresponded to approximately 95% and 80% inhibition of cell proliferation in
normal and cancer cells, respectively. Combinations of falcarinol and falcarindiol added to normal
and cancer cells showed a synergistic response for the inhibition of cell growth. Furthermore, the
oxidized form of falcarinol, falcarinon, showed a significantly less growth inhibitory effect in intestinal
cells of both normal and cancer origin; hence, a hydroxyl group at C-3 may be important for activity
of falcarinol-type polyacetylenes. Extracts of carrots, containing different amounts of falcarinol,
falcarindiol, and falcarindiol 3-acetate had significant inhibitory effects on both normal and cancer
cell proliferation. In cancer cells, the extract containing the highest concentration of falcarinol tended
to have the highest growth inhibitory effect, in accordance with a higher potency of falcarinol than
falcarindiol. The present study demonstrates that aliphatic C17-polyacetylenes are potential anti-
cancer principles of carrots and related vegetables and that synergistic interaction between bioactive
polyacetylenes may be important for their bioactivity.
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INTRODUCTION
Epidemiological studies have provided evidence that a diet high
in fruit and vegetables is associated with a reduced risk for the
development of certain types of cancer, cardiovascular diseases,
diabetes, and other diseases (1-7). Compounds associated with
the health promoting effects of vegetables are glucosinolates
and other organosulfur compounds and their degradation pro-
ducts, carotenoids, phytosterols, polyphenols, vitamins, and diet-
aryfibers(1,7).Themechanismsforthe protectionoftheseclasses
of natural products are mostly unknown and may only in part
explain the health effects of vegetables. Consequently, in recent
years focus has been on other types of potential health promoting
compounds. One of these groups of compounds is aliphatic
C17-polyacetylenes of the falcarinol-type (Figure 1)( 7-13), which
are common in carrots and related vegetables such as parsley,
celery,parsnip,andfennel(10,11,14)aswellasinmedicinalplants
such as ginseng (15,16). Polyacetylenes ofthe falcarinol-type have
shown many interesting bioactivities including anti-inflamma-
tory (11, 13, 16), antiplatelet-aggregatory (11, 16-18), cyto-
toxic (10,11,16,19,20), and antitumor activity (9,22)a sw e l la s
activity against bacteria and mycoplasma (21). Falcarinol appears
to be the most bioactive among polyacetylenes of the falcarinol-
type. The bioactivity of falcarinol is probably associated with its
hydrophobicity and its ability to form an extremely stable carbo-
cation with the loss of water, thereby acting as a very reactive
alkylating agent toward various biomolecules (9, 11). This is
supported by the fact that falcarinol is a strong contact aller-
gen (23). A similar mode of action is expected for other falcarinol-
type polyacetylenes with a hydroxyl group at C-3 (9,11).
The beneficial effects of polyacetylenes of the falcarinol-type
occur at nontoxic concentrations and thus represent pharmaco-
logically useful properties indicating that polyacetylenes may be
importantnutraceuticalsofvegetables.Inthehumandiet,carrots
are the major dietary source of falcarinol-type polyacetylenes, in
particular falcarinol and falcarindiol (8, 13, 14). It has been
demonstrated that falcarinol but not β-carotene could stimulate
differentiationofprimarymammaliancellsofmammaryoriginin
concentrations between 1 ng/mL and 10 ng/mL falcarinol. Toxic
effects were found >50 ng/mL falcarinol, while β-carotene had
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noeffectevenat100μg/mL(8).Thisbiphasiceffect(hormesis)on
cell proliferation has also recently been demonstrated for falcar-
indiol (24). This is fully in accordance with the hypothesis that
toxic compounds have beneficial effects at certain lower concen-
trations (25). Therefore, falcarinol-type polyacetylenes appear to
be the bioactive components in carrots that could explain their
health promoting properties, rather than carotenoids, polyphe-
nols, or other types of primary and/or secondary metabolites.
This is also in accordance with a recent study by Metzger
et al. (13) who found that the anti-inflammatory activities of
purple carrot cultivars was not due to the high levels of poly-
phenols but instead to their content of falcarinol-type polyacety-
lenes. Studies on the bioavailability of particular falcarinol in
humans support the hypothesis that aliphatic C17-polyacetylenes
of the falcarinol-type may play an important role in human
health(7,11).Whenfalcarinolwas administeredorallyvia carrot
juice (13.3 mg falcarinol/L carrot juice) in amounts of 900 mL, it
was rapidly absorbed, reaching a maximum concentration in
serum of 2.5 ng/mL at 2 h after dosing (7,11). This is within the
range where the in vitro data indicate a potentially beneficial
physiological effect and a possible inhibitory effect on the pro-
liferation of cancer cells (8,12).
The potential anticancer activity of carrots and falcarinol has
been demonstrated in an established rat model for colon cancer
by injections of the carcinogen azoxymethane in the inbred rat
strain BDXI (9). The carrot and falcarinol treatments showed a
significant tendency to reduce the number of (pre)cancerous
lesions (aberrant crypt foci) with increasing size of lesions in
physiologically relevant concentrations, i.e., in amounts corre-
sponding to a daily human consumption of 400-600 g fresh
weight of carrot (9). In this study, the effect of the falcarinol diet
was shown to have a larger effect on pre(cancerous) lesions
compared to that in the carrot diet, although the differences
betweenthefalcarinolandthecarrotdietwasnotsignificant.This
could indicatethatother compounds incarrotsmayinteractwith
falcarinol thereby affecting its effectiveness in vivo, in particular
itsanticancereffect.Thisraisessomeinterestingquestionsregard-
ing the interaction between polyacetylenes and other metabolites
in carrots. For example, is the anticancer effect of falcarinol
affected by other carrot polyacetylenes such as falcarindiol, and
ifyes,howdoesthisinteractionmostlikelyaffectthebioactivityof
falcarinol?Alternatively,isthebioactivityofcarrotpolyacetylenes
in vivo affected by the presence of other metabolites in carrots?
In an attempt to answer these questions, the differential effect
of common polyacetylenes of the falcarinol-type (falcarinol,
falcarindiol, and panaxydol) as well as different combinations
of falcarinol and falcarindiol and carrot extracts with different
polyacetylene profiles on the proliferation of human intestinal
epithelialcellsofnormal(FHs74Int.) andcancer(Caco-2)origin
were investigated. The hypothesis that a hydroxyl group at C-3 is
important for the bioactivity of falcarinol-type polyacetylenes
was investigated by comparing the growth inhibitory effect of
falcarinol and the oxidized form of falcarinol, falcarinon, on
intestinal cell proliferation.
MATERIALS AND METHODS
Chemicals and Materials. Ethyl acetate (EtOAc), ethanol (EtOH,
96%),andn-hexaneofhigh-performanceliquidchromatography(HPLC)
grade (99.9% HPLC grade) and diethyl ether (Et2O; 99.9% p.a. for GC)
were obtained from Sigma-Aldrich (Steinheim, Germany). Activated
manganese(IV) oxide (MnO2;R e a g e n t P l u sg 99%) and anhydrous
sodium sulfate (Na2SO4) were obtained from Sigma-Aldrich. Preparative
TLCplates(20 20cm,silicagel60F254,2.5mmthickness)wereobtained
from Merck (Darmstadt, Germany).
Polyacetylene Standards. Authentic standards of the polyacetylenes
(3R)-falcarinol and (3R,8 S)-falcarindiol (Figure 1)w e r ei s o l a t e df r o m
2.5 kg of carrot roots (Daucuscarota,cv. Bolero) and (3R)-panaxydoland
(3R)-falcarinol (Figure 1) from 2 kg of American ginseng (Panax
quinquefolium) roots according to the procedure described by Kidmose
et al. (14) and Christensen et al. (15), respectively. Falcarinol, falcarindiol,
andpanaxydolwereobtainedinapurity>98%,whichwasdemonstrated
by analyzing the isolated polyacetylenes by reverse phase (RP)
HPLC-photodiode array detection (PAD) according to the method
described by Christensen and Kreutzmann (34). Polyacetylenes were
identified by UV, mass spectrometry (MS) [gas chromatography
(GC)-MS (EI, 70 eV)], NMR (
1Ha n d
13CN M R ,a n d
1H-
1Ha n d
1H-
13CcorrelationspectroscopyrecordedinCDCl3withTMSasinternal
standard), and optical rotation, and the complete spectral data set
corresponded fully with literature values for falcarinol (9, 22, 26-28),
falcarindiol (22,27-29), and panaxydol (19,30-32), respectively.
Falcarinon (Figure 1 was produced by the oxidation of falcarinol by
activatedMnO2(33).ActivatedMnO2(100mg)wasaddedtoasolutionof
falcarinol (25 mg) in Et2O (50 mL) and the mixture stirred at room
temperature for 2 h under dark conditions. The reaction mixture was
filteredandtheresiduewashedwithEt2O.Thefiltratewasconcentratedin
vacuo (30 C) in dim light and the residue purified by preparative TLC
(n-hexane-Et2O, 3:1) to give 18 mg of falcarinon as a pale yellow oil in a
purity >98% as shown by RP-HPLC-PAD (34). UV λmax (Et2O): 228,
262,276,292nm.GC-MS(EI,70eV):m/z242[M]
þ (9),185(5),171(11),
157(57),145(36),143(20),131(63),129(80),128(45),117(100),115(83),
103 (87), 91 (59), 77 (76), 55 (94).
1H NMR (300 MHz, CDCl3,T M Sa s
internalstandard):δ0.88(3H,t,7.1Hz,H-17),1.28(8H,m,H-13-H-16),
1.37(2H,m,H-12),2.04(2H,dt,7.0,7.5Hz,H-11),3.12(2H,d,6.9Hz,H-
8), 5.38 (1H, m, H-9), 5.57 (1H, m, dtt, 1.8, 7.5, 10.5 Hz, H-10), 6.19 (1H,
dd, 0.9,10.1 Hz, H-1),6.40(1H, dd, 10.1, 17.4Hz, H-1), 6.55(1H, dd, 0.9,
17.4 Hz, H-2).
13C NMR (75 MHz, CDCl3, TMS as internal standard): δ
14.1 (CH3, C-17), 18.0 (CH2, C-8), 22.6 (CH2, C-16), 27.3 (CH2,C - 1 1 ) ,
29.1 (CH2, C-14), 29.2 (CH2, C-13), 29.2 (CH2, C-12), 31.8 (CH2,C - 1 5 ) ,
63.6 (C, C-6), 70.6 (C, C-5), 77.1 (C, C-7), 88.0 (C, C-4), 120.7 (CH, C-9),
133.9 (CH, C-10), 134.1 (CH2, C-1), 137.8 (CH, C-2), 177.8 (C, C-3).
Carrot Root Extracts for Testing. Frozen carrot shreds (20 g) from
the cultivars cv. Bolero (carrot extract 1) and cv. Purple Haze (carrot
extract 2) were homogenized to a puree using an Ultra-Turrax T25 for
1 min followed by extraction with 60 mL of EtOAc overnight under
stirring at room temperature. Before stirring, the samples were exposed to
ultrasound for 10 min. After the first extraction, the samples were
extracted with an additional 60 mL of EtOAc for 3 h under stirring at
room temperature. The EtOAc extracts were combined and the water
removed from the combined extract by adding anhydrous Na2SO4 (15 g)
followedbyfiltrationthroughaMunktellfilterpaper,grade3W.Thedried
extract was evaporated in vacuo at 25 C in dim light, and the residue
obtained was dissolved in EtOH (5 mL) and filtered through a 0.45 μm
Figure 1. Chemical structures of the polyacetylenes falcarinol, falcarindiol,
panaxydol, and falcarinon tested on human intestinal epithelial cells of
normal(FHs74Int.)andcancer(Caco-2)origininthepresentinvestigation.8292 J. Agric. Food Chem., Vol. 57, No. 18, 2009 Purup et al.
Nylon, Cameo filter (MSI, Westborough, MA) and analyzed by RP-
HPLC-PADforfalcarinol, falcarindiol,andfalcarindiol3-acetateaccord-
ing to the method described by Christensen and Kreutzmann (34).
Cell Culture. Caco-2 cells (a kind gift from Dr. Jan Trige Rasmussen,
Protein Chemistry Laboratory, University of Aarhus, Denmark) were
culturedin96-wellplatesatadensityof4000cells/wellinDulbecco’sminimal
essential medium (DMEM) (Gibco 11960-044), supplemented with fetal
calf serum (FCS, 10%; Cambrex Bio Science, Copenhagen, Denmark),
N-(2hydroxyethyl)piperazine-N0-ethanesulfonic acid (HEPES) (10 mM; In-
vitrogen A/S, Ta ˚ strup, Denmark), Glutamax (2 mM; Invitrogen A/S), and
antibiotic solution (P-3539; Sigma-Aldrich A/S, Vallensbæk Strand,
Denmark) containing penicillin and streptomycin for 24 h (pretreatment
period). FHs 74 Int. cells (ATCC; purchased from LGC Nordic AB, Boras,
Sweden) were cultured in 96-well plates at a density of 1500 cells/well in
DMEM(Gibco42430-025),supplementedwithfetalcalfserum(FCS,10%;
Cambrex Bio Science, Copenhagen, Denmark), HEPES (10 mM; Invitrogen
A/S, Ta ˚ strup, Denmark), bovine insulin (7.5 mg/L; Sigma-Aldrich A/S),
human recombinant EGF (30 μg/L; Austral Biologicals, San Ramon CA,
U S A ) ,N C T C - 1 3 5w i t hg l u t a m i n( 8 % ;I n v i t r o g e nA / S ) ,n o n e s s e n t i a la m i n o
acids(1%;InvitrogenA/S),sodiumpuruvate(0.4mM;InvitrogenA/S),oxa-
loacetate (0.1 g/L; Sigma-Aldrich A/S), Glutamax (2 mM; Invitrogen A/S),
andantibioticsolution(P-0781;Sigma-AldrichA/S) containingpenicillinand
streptomycin for 24 h (pretreatment period). At 60 to 80% confluence, cells
were washed carefully with phosphate buffered saline (PBS) (Invitrogen
A/S), and treatment medium (200 μL per well in 96-well plates) was added to
individual wells for a total of 72 h, with medium changed after 48 h. For each
cell line, growth curves were obtained with different numbers of cells and
different concentrations of FCS for 8-10 successive days of culture. In this
way,weensuredthatcellswereinthesigmoidphaseofthegrowthcurvewhen
components to be tested were added to the culture medium.
Treatment medium contained falcarinol, falcarindiol, or panaxydol in
different concentrations (0.001, 0.01, 0.1, 1, 2.5, 5, 10, and 20 μg/mL),
falcarinolorfalcarinonindifferent concentrations (1,2.5,5 10, and 20μg/
mL), or carrot extracts (0.01, 0.05, 0.1, 0.5, and 1% in culture medium).
These treatment media were prepared from stock concentrations of
polyacetylenes in 96% EtOH or carrot extracts resolubilized in 96%
EtOH. Concentrations of EtOH in culture media never exceeded 1%.
Experiments also included studies of potential synergistic and/or antag-
onistic effects of quantitative major and most bioactive polyacetylenes in
carrots.Forthesestudies,falcarinolandfalcarindiolwereaddedtoculture
medium in combinations. Keeping one of the polyacetylenes constant at
10 ng/mL or 1 μg/mL, the two compounds were tested for effects in the
ratios 1:1, 1:5, 1:10, 5:1, and 10:1. Treatment medium furthermore con-
tained FCS (Cambrex Bio Science, Copenhagen, Denmark) in concentra-
tions of either 0.625% or 10%. Cell proliferation was determined by a
resazurin metabolism assay (AlamarBlue, BioSource, AH diagnostics,
Aarhus, Denmark). Cell culture medium was carefully aspirated and the
AlamarBlue reagent was added to all wells and measured after 2 h
incubation according to the manufacturer.
Statistics. Statistical analyses were performed using the general linear
models procedure (PROC GLM) of SAS Institute Inc. Different concen-
trations of the three polyacetylenes (Figure 2)w e r et e s t e du s i n gam o d e l
including the systematic effects of the source of polyacetylenes (n=3),
concentrations of polyacetylenes (nine levels), and their interaction. The
effect of the assay (n = 2) was included as a blocking factor. Different
concentrations of falcarinol and falcarinon (Figure 3)w e r et e s t e du s i n ga
model including the systematic effect of polyacetylenes (n=2), concen-
tration of polyacetylenes (five levels), and their interaction. The effect of
the assay (n = 2) was included as a blocking factor. Different concentra-
tions of the two carrot extracts (Figure 4)w e r et e s t e du s i n gam o d e l
Figure 2. Effectofincreasingconcentrationsoffalcarinol,falcarindiol,andpanaxydoloncellproliferationin(A,B)Caco-2and(C,D)FHs74Int.cellscultured
for72hineither(A,C) 0.625%FCSor(B,D) 10%FCS.Valuesareleast-squaresmeansobtainedfromculturesinquadruplesamplesfromtwoexperiments
andpresentedasrelativetoproliferationobtainedinmediumwithoutpolyacetylenes(basalmedium).Standarderrorofthemean(SEM)valuesobtainedinthe
ANOVA analysiswere0.15,0.08, 0.06,and 0.04 (relative values) for A, B, C,a n dD, respectively. Valuessignificantly different from proliferation obtained in
basal medium are indicated: c, P < 0.05; b, P < 0.01; a, P < 0.001.Article J. Agric. Food Chem., Vol. 57, No. 18, 2009 8293
including the systematic effect of extract (n = 2), concentration of extract
(five levels), and their interaction. The effect of the assay (n =2 )w a s
included as a blocking factor. The residual mean error was used as the
error term for F-tests. All results shown in Figures 2-4 are least-squares
meansobtainedfromculturesinquadruplesamplesfromtwoexperiments
and presented as relative to proliferation obtained in basal medium.
RESULTS AND DISCUSSION
The effects of falcarinol-type polyacetylenes and carrot ex-
tracts were evaluated in two different intestinal cell lines of
normal and cancer origin, respectively. We have previously used
both of these intestinal epithelial cell lines for identification of
bioactive components in complex natural mixtures such as
milk (35, 36). To be able to compare results obtained from two
differentcelllines,growthcurveswereperformedforeachcellline
to ensure that cells were in the sigmoid phase of the growth curve
when components to be investigated were added to the culture
medium. Therefore, the initial number of cells was different for
the two individual cell lines.
Effect of Polyacetylenes on Intestinal Cell Proliferation. The
effects of the polyacetylenes, falcarinol, falcarindiol, and panax-
ydolwerefirstevaluatedinthehumanintestinalepithelialcellline
ofcancerorigin,Caco-2,usingaresazurinmetabolismassayasan
index of cell proliferation. Treatment of the cells with concentra-
tionsrangingfrom1ng/mLto20μg/mLshowedahormesiseffect
of all three polyacetylenes. Falcarinol, falcarindiol, and panax-
ydol in a concentration of 100 ng/mL increased cell proliferation
by30,42,and60%underbasalgrowthconditions(0.625%FCS)
(P <0 . 0 5 ;Figure 2A). However,inthe presenceof 10% FCS, no
significant increase in cell proliferation was observed with the
three polyacetylenes (Figure 2B). Treatment with falcarinol at a
concentration of 2.5 μg/mL, and falcarindiol and panaxydol at
concentrations of 10 μg/mL significantly reduced proliferation
under basal growth conditions (P <0 . 0 5 ;Figure 2A). In the
presence of 10% FCS, concentrations of 5, 20, and 10 μg/mL of
falcarinol, falcarindiol, and panaxydol, respectively, were needed
to reduce proliferation significantly (P <0 . 0 1 ;Figure 2B). The
relative inhibitory potency was falcarinol > panaxydol > fal-
carindiolwithconcentrationscorrespondingto50%inhibitionof
basalresponseof2.5-5μg/mL,5-10μg/mL,and10-20μg/mL,
respectively. Maximal inhibition at 20 μg/mL corresponded to
approximately 80% inhibition of cell proliferation under basal
growth conditions (Figure 2A). Under FCS stimulated growth
conditions,concentrationscorrespondingto50%inhibitionwere
5-10 μg/mL, 10-20 μg/mL and >20 μg/mL, for falcarinol,
panaxydol, and falcarindiol, respectively. Maximal inhibition at
20 μg/mL corresponded to approximately 90, 65, and 30% for
falcarinol, panaxydol, and falcarindiol, respectively (Figure 2B).
We also determined whether falcarinol, falcarindiol, and
panaxydol had similar effects in the normal human intestinal
epithelial cell line, FHs 74 Int. In these cells, no hormesis effect
was observed. Instead, a significantly inhibitory effect on pro-
liferationwas seenwith concentrationsoffalcarinol, falcarindiol,
and panaxydol at 5, 10, and 2.5 μg/mL, respectively (P <0 . 0 0 1 ;
Figure 2C and D) in the presence of both 0.625 and 10% FCS,
Figure 3. Effectofincreasingconcentrationsoffalcarinolandfalcarinonon
cellproliferationin(A)Caco-2and(B)FHs74Int.cellsculturedfor72hin
0.625% FCS. Values are least-squares means obtained from cultures in
quadruple samples from two experiments and presented as relative to
proliferation obtained in medium without falcarinol (basal medium).S E M
values obtained from ANOVA analysis were6.4 and15.3(relativevalues)
for A and B, respectively. Values significantly different from proliferation
obtained in basal medium are indicated: b, P <0 . 0 1 ;a ,P < 0.001. Values
showing a tendency to be different from proliferation obtained in basal
medium are indicated: †, P <0 . 1 .
Figure 4. Effect of increasing concentrations of carrot extracts on cell
proliferation in (A) Caco-2 and (B) FHs 74 Int. cells cultured for 72 h in
0.625% FCS. Concentrations correspond to percentages of the stock
solutionsgiven inTable 2. Valuesareleast-squares means obtained from
cultures in quadruple samples from two experiments and presented as
relative to proliferation obtained in medium without extracts (basal
medium). SEM values obtained in the ANOVA analysis were 2.8 and
7.5(relativevalues)forAandB,respectively.Valuessignificantlydifferent
from proliferation obtained in basal medium are indicated: c, P < 0.05; a,
P < 0.001.Carrot extract1 contained approximately50% oftheamount of
falcarinolpresentincarrotextract2,butapproximately4and2timesmore
of falcarindiol and falcarindiol 3-acetate than in carrot extract 2.8294 J. Agric. Food Chem., Vol. 57, No. 18, 2009 Purup et al.
except for falcarindiol which had no inhibitory effect in the pre-
sence of 10% FCS. The relative inhibitory potency was panax-
ydol>falcarinol>falcarindiolwithconcentrationscorrespond-
ing to 50% inhibition of basal response of 1-2.5 μg/mL, 2.5-
5 μg/mL, and 10-20 μg/mL, respectively. When 10% FCS was
present in the culture medium, concentrations corresponding to
50% inhibition were 1-2.5 μg/mL and 5-10 μg/mL for panax-
ydol and falcarinol, respectively (Figure 2C and D).
The present study shows that falcarinol, falcarindiol, and
panaxydol affect cell proliferation of human intestinal cells in a
dose-dependent way and that the presence of FCS in culture
mediumalsoinfluencestheseresponses.Inarecentstudy,Caco-2
cells were chosen as the in vitro model for assessment of the
bioactivity of falcarinol, but falcarindiol and panaxydol were not
examined (12). However, the effect of falcarinol was only studied
in the presence of 10% FCS in the culture medium. Such high
concentration of FCS in culture medium may protect intestinal
cells from growth-inhibitory compounds and furthermore may
include relatively high concentrations of compounds that affect
the bioactivity of the tested compounds. This may explain why
the hormesis effect of polyacetylenes obtained in Caco-2 cells at
0.625% FCS could not be seen in the presence of 10% FCS and
that higher concentrations of polyacetylenes were needed to
inhibit cell proliferation (Figure 2). These results indicate that
FCS in high concentrations in culture medium protects intestinal
cells against the inhibitory effects of the tested polyacetylenes. On
the basis of these observations, we recommend testing the
bioactivity of falcarinol-type polyacetylenes in Caco-2 cells and
similar cell models in low concentrations of FCS.
Theinhibitorypotency wasclearlydifferentbetween the tested
polyacetylenesinthecancerandnormalintestinalcells.InCaco-2
cells,falcarinolwasthemostpotentinhibitorofcellproliferation,
while in FHs cells, panaxydol was more potent than falcarinol.
Theeffectoffalcarindiolwassimilarinbothcelllines,althoughits
effect was much lower with 50% inhibition of basal response at
10-20μg/mL(Figure2).Thepresentresultsconfirmtheresultsof
other studies that falcarinol and panaxydol are much more
cytotoxic than falcarindiol and similar polyacetylenes of the
falcarinol-type such as falcarindiol 3-acetate and 8-O-methylfal-
carindiol (10). Falcarindiol has, for example, the ability to
generatetwoactivecentersfornucleophilicattack, whichreduces
thelipophiliccharacterofthiscompoundandhenceitsreactivity,
which could explain the lower reactivity of this compound
compared to that of falcarinol and panaxydol. The lower reac-
tivity and potential anticancer effect of falcarindiol compared to
that of falcarinol are also in accordance with the observed
nonallergenic properties of falcarindiol (23). The inhibitory
activityofthetestedpolyacetylenestowardCaco-2cellstherefore
confirm that the anticancer activity of polyacetylenes of the
falcarinol-type is associated with their ability to form extremely
stable carbocations, thereby acting as very reactive alkylating
agents toward biomolecules.
EffectofOxidationofFalcarinolonIntestinalCellProliferation.
The importance of a hydroxyl group in the C-3 position of
falcarinol was investigated by testing the inhibitory effect of the
oxidized form of falcarinol, falcarinon, on intestinal cell prolif-
eration. Falcarinol and falcarinon, were added to Caco-2 and
FHs 74 Int. cells for comparison of the effects on cell prolifera-
tion. In accordance with the results reported above, falcarinol
significantly inhibited cell proliferation in Caco-2 cells at 2.5 μg/
mL (P < 0.01) and in FHs 74 Int. cells at 5 μg/mL (P <0 . 0 1 )
(Figure 3). Falcarinon, however, only inhibited proliferation in
Caco-2 cells at the concentration of 20 μg/mL (P <0 . 0 0 1 )a n d
only tended to decrease proliferation in FHs 74 Int. cells at this
concentration (P < 0.10). Furthermore, the dose of 20 μg/mL
only caused 40-45% reduction in cell proliferation, and there
were no differences between normal and cancer cells (Figure 3).
These results demonstrate that the oxidized form of falcarinol,
falcarinon, is a much less potent inhibitor of cell proliferation in
intestinal cells of both normal and cancer origin and strongly
support the hypothesis that the mode of action of falcarinol-type
polyacetylenes is due to their ability to lose water through the
hydroxyl group at C-3, thereby generating reactive carbocations.
This mode of action of falcarinol-type polyacetylenes makes it
reasonable to assume that these compounds can affect each
other’s anticancer activity in an antagonistic and/or synergistic
manner. Consequently, the inhibitory effect of falcarinol and
falcarindiolonCaco-2andFHs74Int.cellswastestedindifferent
concentration ratios. Keeping one of the polyacetylenes constant
ateither10ng/mLor1μg/mL, Caco-2and FHs74Int.cellswere
incubated with falcarinol and falcarindiol in the ratios 1:1, 1:5,
1:10, 5:1, and 10:1. These studies were again performed in a
medium containing 0.625% FCS or 10% FCS. When a concen-
tration of 10 ng/mL of falcarinol or falcarindiol was added to
Caco-2orFHs 74Int.cells ateither0.625%or10% FCS present
in the medium, increasing the concentration of one or the other
polyacetylene showed no difference from what would have been
expected from the single-compound assay (data not shown).
However, at a concentration of 1 μg/mL of falcarinol, a synergi-
stic response for the inhibitory effect of cell proliferation was
observed by adding falcarindiol in 1, 5, and 10 times the
concentration of falcarinol (Table 1) for both Caco-2 and FHs
74Int.cellsbutonlywith0.625%FCSpresentinthemedium.By
keeping falcarindiol constant, no synergistic response of cell
proliferation was observed by adding falcarinol in 5 and 10 times
the concentration of falcarindiol in Caco-2 nor FHs 74 Int. cells
(Table 1).
The results of these studies demonstrate that falcarindiol in
lowdosescanhaveverypotentinhibitoryeffectsonintestinalcell
proliferation when found in combination with low doses of
falcarinol (Table 1). Synergistic interactions could therefore be
an important factor in relation to the anticancer activity of
falcarinol-type polyacetylenes, although this activity clearly de-
pends on the concentration and the ratio of the compounds.
Effect of Carrot Extracts on Intestinal Cell Proliferation. To
further determine the effect of polyacetylenes in combinations
andhencetheirpossiblesynergisticinteractions,theeffectsoftwo
Table 1. Effects of Different Ratios of Falcarinol and Falcarindiol on Caco-2
and FHs 74 Int. Cells in Culture Medium Containing 0.625% FCS
a
falcarinol (μg/mL)
015 1 0
Caco-2 cells
falcarindiol (μg/mL) 0 1.0 1.01 ( 0.25 0.36 ( 0.25 0.18 ( 0.01
1 1.35 ( 0.36 0.71 ( 0.08
b 0.58 ( 0.04 0.22 ( 0.08
5 1.03 ( 0.32 0.53 ( 0.06
b nd
c nd
10 0.52 ( 0.17 0.17 ( 0.03
b nd nd
FHs 74 Int. cells
falcarindiol (μg/mL) 0 1.0 1.02 ( 0.06 0.32 ( 0.35 0.06 ( 0.01
1 0.92 ( 0.01 0.51 ( 0.30
b 0.47 ( 0.01 0.36 ( 0.28
5 0.90 ( 0.04 0.34 ( 0.24
b nd nd
10 0.60 ( 0.14 0.14 ( 0.13
b nd nd
aCellswereculturedfor72h,andcellproliferationwasdeterminedbyaresazurin
metabolismassay.Mean(standarddeviationisshownforeachcombinationofthe
two tested polyacetylenes. Data are presented relative to cell proliferation obtained
in medium without polyacetylenes for two individual experiments.
bSignificant
synergisticinhibitoryeffecton cellproliferationcomparedtosingle-compound assay
(P < 0.01).
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carrot EtOAc extracts were studied in Caco-2 and FHs 74 Int.
cells. Concentrations of falcarinol, falcarindiol, and falcarindiol
3-acetate in carrot extracts are shown in Table 2. Carrot extract 1
containedapproximately50%ofthefalcarinolincarrotextract2,
but approximately 4 and 2 times more falcarindiol and falcar-
indiol 3-acetate, respectively, than carrot extract 2. Both extracts
had significant inhibitory effects on intestinal cell proliferation in
the highest concentration of 0.5 and 1% of extract in culture
medium (Figure 4). In Caco-2 cells, carrot extract 2 tended (P <
0.10) to be a more potent inhibitor of proliferation than carrot
extract 1, as significant inhibition was obtained also with 0.1%
extract giving an approximate 20% decrease in proliferation
(Figure 4A). In FHs 74 Int. cells, there was no difference between
theeffectsofthetwoextracts(Figure4B), but the effectatagiven
concentration was larger than that in Caco-2 cells. At the highest
concentrationsofextracts,cellproliferationwasreducedto6%of
proliferation in FHs 74 Int. cells, while in Caco-2 cells, cell
proliferation was reduced to only 36% (Figure 4).
The more potent inhibitory activity of carrot extract 2 than of
carrot extract 1 in Caco-2 cells (Figure 4A) is in accordance with
the approximately 3 times higher concentration of falcarinol in
carrot extract 2, as falcarinol is a more potent inhibitor than
falcarindiol (Figure 2). Comparing the effects of the carrot
extracts with the effects of falcarinol or falcarindiol alone, we
showed that the mixture of polyacetylenes found in the extracts
was more potent in inhibiting cell proliferation. As an example,
the1%carrotextract1preparedfromastocksolutionbydiluting
100 times in cell culture medium (Table 2) contained falcarinol,
falcarindiol, and falcarindiol 3-acetate in concentrations of 2.81,
5.96, and 1.96 μg/mL, respectively, and caused a reduction in
cell proliferation to 36%. For comparison, a concentration of
2.5 μg/mL of falcarinol decreased proliferation to 68%, while
falcarindiol caused no decrease in cell proliferation (Figures 2
and 4,a n dTable 2). Concentrations in falcarinol of 5 μg/mL or
falcarindiolof10-20μg/mLwererequiredtoobtainadecreasein
cell proliferation corresponding to 36%. However, addition of
carrot extract 2 to Caco-2 cells did not decrease cell proliferation
morethancarrotextract1despiteaconcentrationinfalcarinolof
6.46 μg/mL. These studies suggest that falcarinol in combination
with the relatively high concentrations of falcarindiol and falcar-
indiol3-acetateincarrotextract1hasasynergisticeffectonCaco-
2cellproliferation.InFHs74Int.cells,asimilarsynergisticeffect
canbesuggestedascarrotextract 1or2bothcausedadecreasein
cellproliferationto30and6%inconcentrationsof0.5%and1%,
respectively, of the extracts. To obtain such decreases in cell
proliferationofFHs74Int.cellsbyfalcarinolalone,a concentra-
tion of 10 μg/mL would be necessary.
The synergistic effect observed between falcarinol and other
falcarinol-type polyacetylenes in carrots are contradictory to the
anticancereffectpreviouslyobservedforacarrotdietcomparedto
afalcarinoldietinratswithinduced(pre)cancerouslesions(9).The
present results therefore clearly suggest that other metabolites in
carrots to some extent may interactwithfalcarinol and other poly-
acetylenes in carrots, thereby affecting their effectiveness in vivo.
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